| Literature DB >> 27268285 |
Hue Leu1, Naotoshi Sugimoto2, Masaki Shimizu3, Tomoko Toma4, Taizo Wada5, Kunio Ohta6, Akihiro Yachie7.
Abstract
Shiga toxin (STX) is one of the main factors inducing hemorrhagic colitis and hemolytic-uremic syndrome (HUS) in infections with STX-producing Escherichia coli (STEC). Approximately 62% of patients with HUS showed symptoms of encephalopathy in the 2011 Japanese outbreak of STEC infections. At that time, we reported elevated serum concentrations of tumor necrosis factor (TNF)-α in patients with acute encephalopathy during the HUS phase. In the current study, we investigated whether TNF-α augments the effects of STX in glial cell lines and primary glial cells. We found that TNF-α alone or STX in combination with TNF-α activates nuclear factor-κB (NF-κB) signaling and inhibits growth of glial cells. The magnitude of the NF-κB activation and the inhibition of cell growth by the STX and TNF-α combination was greater than that obtained with TNF-α alone or STX alone. Thus, this in vitro study reveals the role of TNF-α in glial cells during STEC infections.Entities:
Keywords: Encephalopathy; Nuclear factor-κB; Outbreak; Shiga toxin
Mesh:
Substances:
Year: 2016 PMID: 27268285 DOI: 10.1016/j.intimp.2016.05.022
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932